Awards and Patent

Invention patent

The company mainly develops a series of genetically engineered viruses for tumor treatment. We have successfully developed three genetically engineered adenovirus with independent intellectual property rights: H101, H102 and H103. H101 (trade name: Oncorine) was officially launched in July 2006, H102 is in preclinical research, and phase I clinical trial of H103 has been completed.
The company has 7 domestic invention patents, 1 international invention patent, 5 utility patents. The first GMP-certified production line for oncolytic adenovirus in China.

Safe Production Certificate

1150 Guiqiao Road.,China (Shanghai) Pilot Free Trade Zone

sunwaybio@sunwaybio.com.cn

(+86) 021-50310270

Company Wechat

Shanghai Sunway Biotech Co., Ltd.©All rights reserved.

(沪)-非经营性-2017-0090 沪ICP备05059751号-1

Legal Statement